Maui Coronavirus Updates

FDA Approves Emergency Use of Pfizer-BioN Tech Vaccine for Children 12-15

May 10, 2021, 1:58 PM HST
* Updated May 12, 6:37 AM
Listen to this Article
1 minute
Loading Audio... Article will play after ad...
Playing in :00

The US Food and Drug Administration approved emergency authorization use of the Pfizer-BioNTech vaccine for children aged 12-15.

The US Food and Drug Administration today approved emergency authorization use of the Pfizer-BioN Tech vaccine for children aged 12-15.

“Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic,” Acting FDA Commissioner Janet Woodcock said in a statement.

Pfizer’s two-shot vaccine was authorized in the United States for people 16 years and older last year. Vaccines made by Moderna and Johnson & Johnson are available to those 18 and older.

Five days ago, Canada approved use of the Pfizer-BioNTech shot for children as young as 12. While childrenʻs cases tend to be milder, they can still spread the disease. COVID-19 cases in children also are a growing proportion of cases as more adults are vaccinated.

The United States had nearing 17 million people in the 12 to 15 age group, about 5.3% of the countryʻs population, according to the Kaiser Family Foundation.


In March, Pfizer and BioNTech said their final-stage trial of 2,260 adolescents showed the vaccine was 100% effective in the 12-to-15 age group. The shot produced antibodies exceeding the level seen in vaccinated young adults. Side effects were consistent with those experienced by 16-to-25 year olds.

E-Mail Newsletters Receive daily or weekly updates via e-mail. Subscribe Now
News Alerts Breaking news alerts on your mobile device. Get the App


This comments section is a public community forum for the purpose of free expression. Although Maui Now encourages respectful communication only, some content may be considered offensive. Please view at your own discretion. View Comments (95)